What You Should Know:
- A new PwC report offers insights into how pharma companies can translate game-changing science into greater returns.
- Despite many major therapeutic advancements within the last decade, returns from pharma companies lagged the S&P 500 by about one-third and biotech underperformed by 60 percent. The stock performance divide between the front and back of the pack has been widening. PwC’s analysis showed that in 2021, the five-year
Read More
Rural Provider Homeward Forms In-Market Partnership with Rite Aid to Support Seniors in Underserved Communities
What You Should Know:
- Homeward, the comprehensive rural care provider network launched by former Livongo titan, Dr. Jenny Schneider, has announced a partnership with Rite Aid to deliver onsite care to rural Americans, starting with Medicare.
- Homeward’s work with Rite Aid will also support the pharmacy retailer’s recently announced plans to double-down on pharmacy services, with increased focus on expansion in underserved communities. This is also Rite Aid’s first push to bring real
Read More
Greenway Health Launches Greenway Secure Cloud
What You Should Know:
- Greenway Health, a leading health information technology services provider, launched Greenway Secure Cloud, a cost-effective, fully bundled, cloud-based electronic health record (EHR) and practice management solution. Greenway Secure Cloud increases the security of patient health information and practice records, eliminates the need to manage software upgrades, and provides scalable, all-inclusive pricing
Read More
Watchmaker Genomics Raises $40M to Expand Clinical Sequencing Product Offerings
What You Should Know:
- Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA raises $40M in an oversubscribed Series A, bringing total funding to date to $53.5M. The round was led by Decheng Capital, with co-investment from Eclipse Ventures.
- Watchmaker Genomics applies advanced enzymology to enable breakthrough applications for the reading, writing, and
Read More
Ordr Secures $40M for Real-Time Connected Device Security Platform
What You Should Know:
- Ordr, a company making the complex problem of securing every connected device — from traditional IT devices to newer and more vulnerable IoT, IoMT or OT — simple, today announced it has raised an additional $40M. The funding round was co-led by Battery Ventures and Ten Eleven Ventures, with participation from new investor Northgate Capital and continuing investors Wing Venture Capital, Unusual Ventures, Kaiser Permanente Ventures, and Mayo Clinic.
Read More
Akili + Roblox Form First of Its Kind Digital Treatment Partnership
What You Should Know:
- Akili’s EndeavorRx, the first and only FDA-cleared video game ADHD treatment for kids, is uniting with Roblox’s global virtual universes forming a first-of-its-kind partnership.
- Initially, the partnership will establish an exclusive Roblox reward exchange for patients that complete their medically prescribed EndeavorRx treatment. The rewards will enable patients to redeem items via the exchange program as soon as this summer.
Delivering A Reimagined
Read More
Survey: Patient Trust Not a Barrier to AI Medical Imaging Adoption
What You Should Know:
According to data from Intelerad, patient trust is not a barrier to AI adoption by medical imaging professionals in the U.S. 64% of respondents either trust or are neutral about a diagnosis solely from AI.
The Intelerad study of over 1,000 healthcare consumers across the U.S. uncovers the impact of healthcare’s digital transformation on the healthcare consumer in a post-pandemic world. The results unveil new insights into patient attitudes toward AI.
Patient
Read More
Survey Reveals 44% of Consumers Avoided Healthcare Due to Cost
What You Should Know:
New price transparency government mandates are on the horizon, but how much does cost really impact consumers? HealthSparq published its Annual Consumer Sentiment Benchmark report, which found that 44% of respondents have avoided getting healthcare services because they were unsure of the costs (compared to 25% last year).
The survey of 1,000+ healthcare consumers unveils their opinions on price transparency in
Read More
Geisinger & Tempus Create AI Model to Identify Structural Heart Disease
What You Should Know:
- Tempus, an $8B precision medicine company, announced a collaborative study with Geisinger focusing on artificial intelligence (AI) model that can accurately identify patients at increased risk of undiagnosed structural heart disease (SHD). The study addresses a critical diagnostic gap – SHD is a progressive disease that affects the valves, walls, chambers, and muscles of the heart, and causes debilitating symptoms or death, yet many patients with the disease go
Read More
RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification
What You Should Know:
- RapidAI, a neurovascular and vascular AI-enhanced clinical decision support and patient workflow receives FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast identification and communication of suspected central pulmonary embolism — further strengthening RapidAI’s industry-leading clinical AI platform.
- Rapid PE Triage & Notification, in conjunction with Rapid Workflow for PE, will enable care teams to more
Read More
